176 related articles for article (PubMed ID: 32272445)
1. Meta-analysis of risk factors for CCLNM in patients with unilateral cN0 PTC.
Sun W; Zheng B; Wang Z; Dong W; Qin Y; Zhang H
Endocr Connect; 2020 May; 9(5):387-395. PubMed ID: 32272445
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
[TBL] [Abstract][Full Text] [Related]
4. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
[TBL] [Abstract][Full Text] [Related]
5. Optimal range of lymph node dissection in patients with unilateral papillary thyroid carcinoma with lateral cervical lymph node metastasis.
Zhang L; Ding Z; Han J; Bi W; Nie C
Front Oncol; 2023; 13():1307937. PubMed ID: 38162482
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.
Zhong X; Lu Y; Yin X; Wang Q; Wang F; He Z
Gland Surg; 2022 Feb; 11(2):378-388. PubMed ID: 35284301
[TBL] [Abstract][Full Text] [Related]
7. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN
Xiao X; Wu Y; Zou L; Chen Y; Zhang C
Gland Surg; 2022 Jul; 11(7):1204-1211. PubMed ID: 35935559
[TBL] [Abstract][Full Text] [Related]
8. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
Zhang Q; Wang Z; Meng X; Duh QY; Chen G
Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.
Hu D; Zhou J; He W; Peng J; Cao Y; Ren H; Mao Y; Dou Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2018 Feb; 16(1):30. PubMed ID: 29439716
[TBL] [Abstract][Full Text] [Related]
11. The characteristics and risk factors of central compartment lymph node metastasis in cN0 papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.
Jin K; Li L; Liu Y; Wang X
Gland Surg; 2020 Dec; 9(6):2026-2034. PubMed ID: 33447553
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: A systematic review and meta-analysis.
Ma B; Wang Y; Yang S; Ji Q
Int J Surg; 2016 Apr; 28():153-61. PubMed ID: 26944586
[TBL] [Abstract][Full Text] [Related]
14. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.
Liu LS; Liang J; Li JH; Liu X; Jiang L; Long JX; Jiang YM; Wei ZX
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1327-1338. PubMed ID: 27645473
[TBL] [Abstract][Full Text] [Related]
15. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
16. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
17. The impact of the multifocality and subtypes of papillary thyroid carcinoma on central compartment lymph node metastasis.
Soylu L; Aydin OU; Ozbas S; Bilezikci B; Ilgan S; Gursoy A; Kocak S
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3972-3979. PubMed ID: 27775804
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].
Huang H; Xu Z; Wang X; Wu Y; Liu S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):771-5. PubMed ID: 26813598
[TBL] [Abstract][Full Text] [Related]
19. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
Qu H; Sun GR; Liu Y; He QS
Clin Endocrinol (Oxf); 2015 Jul; 83(1):124-32. PubMed ID: 25130203
[TBL] [Abstract][Full Text] [Related]
20. Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma.
Zhou J; Li DX; Gao H; Su XL
World J Clin Cases; 2022 Apr; 10(12):3709-3719. PubMed ID: 35647144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
